The Therapeutic Goods Administration issued the company seven infringement notices totaling $93,240 for promoting its nasal spray, Viraleze, via its website and YouTube channel.
Starpharma issued a statement on Monday, and said the company"immediately acted" after they found out.
While most would find such a fine nothing to sneeze at, a global company would probably thumb their nose at the idea of it being a problem.